Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy

Seminars in Oncology

Volumn 30, Issue 2, 2003, Pages 172-177

  Morra, Enrica ^a,b,c,d   Cesana, Clara ^a,b,c,d   Klersy, Catherine ^a,b,c,d   Varettoni, Marzia ^a,b,c,d   Cavanna, Luigi ^a,b,c,d   Canesi, Bianca ^a,b,c,d   Tresoldi, Elisabetta ^a,b,c,d   Barbarano, Luciana ^a,b,c,d   Lazzarino, Mario ^a,b,c,d  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Ospedale Civile   (Italy)

^d Hematology Oncology Studies and Trials (HOST) Group   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENCE JONES PROTEIN; HEMOGLOBIN; IMMUNOGLOBULIN M; PARAPROTEIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; B CELL LEUKEMIA; BONE MARROW DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROTEINURIA; STATISTICAL MODEL; SURVIVAL; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0037397826     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2003.50068     Document Type: Article

References (24)

1. Gandara DR, Mackenzie MR: Differential diagnosis of monoclonal gammopathy. Med Clin North Am 72:1155-1167, 1988
2. Kyle RA, Garton JP: The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62:719-731, 1987
3. Dimopoulos MA, Panayiotidis P, Maulopoulos LA, et al: Waldenström's macroglobulinemia: Clinical features, complications, and management. J Clin Oncol 18:214-226, 2000
4. Dhodapkar MV, Jacobson JL, Gertz MA, et al: Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: Results of United States intergroup trial (Southwest Oncology Group S9003). Blood 98:41-48, 2001
5. García-Sanz R, Montoto S, Torrequebrada A, et al: Waldenström macroglobulinemia: Presenting features and outcome in a series with 217 cases. Br J Haematol 115:575-582, 2001
6. Facon T, Brouillard M, Duhamel A, et al: Prognostic factors in Waldenström's macroglobulinemia: A report of 167 cases. J Clin Oncol 11:1553-1558, 1993
7. Morel P, Monconduit M, Jacomy D, et al: Prognostic factors in Waldenström macroglobulinemia: A report on 232 patients with the description of a new scoring system and its validation on 253 other patients. Blood 96:852-858, 2000
8. Gertz MA, Fonseca R, Rajkumar SV: Waldenström's macroglobulinemia. Oncologist 5:63-67, 2000
9. Owen RG, Johnson SA, Morgan GJ: Waldenström's macroglobulinemia: Laboratory diagnosis and treatment. Hematol Oncol 18:41-49, 2000
10. Owen RG, Barrans SL, Richards SJ, et al: Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors. Am J Clin Pathol 116:420-428, 2001
11. Cesana C, Klersy C, Barbarano L, et al: Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. J Clin Oncol 20:1625-1634, 2002
12. Baldini L, Guffanti A, Cesana BM, et al: Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy. Blood 87:912-918, 1996
13. Kyle RA, Therneau TM, Rajkumar SV, et al: A long-term study on prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346:564-569, 2002
14. Paladini G, Fogher M, Mazzanti G, et al: Gammapatia monoclonale idiopatica. Studio a lungo termine di 313 casi. Recenti Prog Med 80:123-132, 1989
15. Blade J, Lopez-Guillermo A, Rozman C, et al: Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 81:391-394, 1992
16. Kyle RA: "Benign" monoclonal gammopathy after 20 to 35 years of follow-up. Mayo Clin Proc 68:26-36, 1993
17. Van de Poel MHW, Coebergh JWW, Hillen HFP: Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital of Southeastern Netherlands. Br J Haemathol 91:121-125, 1995
18. Dimopoulos MA, Alexanian R: Waldenström's macroglobulinaemia. Blood 83:1452-1459, 1994
19. Gobbi PG, Bettini R, Montecucco C, et al: Study of prognosis in Waldenström's macroglobulinemia: A proposal for a simple binary classification with clinical and investigational utility. Blood 83:2939-2945, 1994
20. Bennett JM, Catovsky D, Daniel MT, et al: Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol 42:567-584, 1989
21. Sahota SS, Forconi F, Ottensmeier CH, et al: Typical Waldenström macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood 100:15051506, 2002
22. Kyrtsonis MC, Vassilakopoulos TP, Angelopoulou MK, et al: Waldenström's macroglobulinemia: Clinical course and prognostic factors in 60 patients. Ann Hematol 80:722-727, 2001
23. Bartl R, Frisch B, Mahl G, et al: Bone marrow histology in Waldenström's macroglobulinaemia. Clinical relevance of subtype recognition. Scand J Haematol 31:359-375, 1983
24. Binet JL, Auquier A, Dighiero G, et al: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206, 1981